Retatrutide (CAS 2381089-83-2) – Wholesale & Research Grade
Retatrutide, a novel therapeutic agent, has garnered significant attention in the fields of metabolic disorders and obesity management. Its unique mechanism of action, which involves the modulation of multiple pathways associated with appetite regulation and energy expenditure, positions it as a promising candidate for future research and clinical applications.
Research Applications
Retatrutide is primarily being investigated for its efficacy in treating obesity and related metabolic conditions. Preliminary studies indicate that this compound may enhance weight loss and improve metabolic parameters, making it a valuable tool in the ongoing battle against obesity. Additionally, researchers are exploring its potential applications in the management of type 2 diabetes, given its impact on insulin sensitivity and glucose metabolism.
Mechanism of Action
The mechanism of action of retatrutide is multifaceted. It acts on various receptors involved in the regulation of appetite and energy balance, leading to reduced food intake and increased energy expenditure. This dual action not only aids in weight loss but also contributes to the improvement of metabolic health markers. Such mechanisms highlight retatrutide's potential as a comprehensive treatment for obesity and its comorbidities.
Solubility and Storage Advice
Retatrutide demonstrates favorable solubility characteristics, making it suitable for various formulation strategies. For optimal stability and efficacy, it is recommended to store retatrutide in a cool, dry place, protected from light. Proper storage conditions are crucial to maintaining the integrity of the compound and ensuring reliable results in research and clinical applications.
Future Research Directions
- Ongoing clinical trials are expected to provide further insights into the long-term efficacy and safety profile of retatrutide.
- Research may expand into combination therapies that include retatrutide, targeting multiple pathways in obesity management.
- Exploring the effects of retatrutide in diverse populations will be essential to understand its broad applicability.
In conclusion, retatrutide represents a significant advancement in the pharmacological approach to obesity and metabolic disorders, with promising avenues for future research and clinical innovation.
| CAS Number | 2381089-83-2 |
|---|---|
| Formula | C221H342N46O68 |
| Mol. Weight | 4731 g/mol |
| IUPAC Name | 20-[[(1S)-4-[2-[2-[2-[[(5S)-5-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(... |
| Grade | HPLC ≥98% |
Synthesis & Storage
Retatrutide is supplied as a lyophilized powder to ensure stability during transit.
For long-term storage of CAS 2381089-83-2, we recommend maintaining at -20°C.
Researchers must reconstitute this peptide with bacteriostatic water or sterile solvent only when ready for use.
Quality Control: All batches undergo rigorous HPLC purity testing (≥98%) prior to dispatch from our USA fulfillment center.